004 Reduced Expression of SOCS3 Predicts Poor Outcome in Epithelial Ovarian Cancer

Viola Heinzelmann‐Schwarz; Margaret Gardiner‐Garden; Susan M. Henshall; Richard A Scolyer; KC Leung; James Scurry; Amy Smith; R. L. Sutherland; Philip O’Brien; Neville F. Hacker

doi:10.1136/ijgc-00009577-200409001-00004

Related publications

Article2007

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.

Eleni Efstathiou, Meletios A Dimopoulos, George Bozas, Efstathios Kastritis, Lia A. Moulopoulos, Alexandros Rodolakis, George Vlahos, Dimitra Gika, Christos Papadimitriou, Aristotelis Bamias

Article2005

In <i>situ</i> proteomics of biomarker expression in epithelial ovarian cancer

Mohammad Kassar, Ziwei Yu, A. Bamias, S. Markakis, Diane Kowalski, Eleni Efstathiou, R. L. Camp, David L. Rimm, D. Psyrri, Meletios A Dimopoulos

Article1992

Alcohol and epithelial ovarian cancer

Carlo La Vecchia, Eva Negri, Silvia Franceschi, Fabio Parazzini, Antonella Gentile, M Fasoli

Article2019

Mon2 predicts poor outcome in <scp>ST</scp>‐elevation myocardial infarction

Eduard Shantsila, Angie Ghattas, Helen R. Griffiths, Professor Gregory Lip

Article2005

Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer

Amanda Psyrri, Mohamad Kassar, Ziwei Yu, A. Bamias, Paul Weinberger, Sonia Markakis, Diane Kowalski, Robert L. Camp, David L. Rimm, Meletios A Dimopoulos